✦ LIBER ✦

Cost-utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting

✍ Scribed by Hallinen, T. A.; Soini, E. J. O.; Eklund, K.; Puolakka, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS58 COST-UTILITY ANALYSIS OF DIFFERENT

✍ Hallinen, TA; Soini, EJ; Eklund, K; Puolakka, K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Strategies after the failure of the firs

✍ Charalampos Papagoras; Paraskevi V. Voulgari; Alexandros A. Drosos 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 388 KB

A Model to Evaluate the Immunogenicity C

✍ Heeg, B.; Majer, I.; Stephens, J.M.; Tarallo, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Tumour Necrosis Factor α Antagonists in

✍ Pier-Luigi Meroni,Guido Valesini 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 966 KB

Comparative effectiveness and safety of

✍ Schoels, M.; Aletaha, D.; Smolen, J. S.; Wong, J. B. 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 750 KB

Retention of tocilizumab and anti-tumour

✍ Hishitani, Y; Ogata, A; Shima, Y; Hirano, T; Ebina, K; Kunugiza, Y; Shi, K; Nara 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 248 KB